Citations

Showing 10 of 108094 citations.

A deep neural network method for analyzing lung density using lung ultrasound surface wave elastography
Zhou, Boran , Zhang, Xiaoming

Mayo Clinic

The Journal of the Acoustical Society of America | April 17, 2018 | Volume: 143 | Issue: 3_Supplement | Pages: 1803-1803

10.1121/1.5035903 Get It

Lung density is directly associated with lung pathology. Computed Tomography (CT) evaluates lung pathology using the Hounsfield unit (HU) but not directly the lung density. We recently developed a lung ultrasound surface wave elastography (LUSWE) technique for measuring the surface wave speed of superficial lung tissue. The objective of this study is to analyze lung density of superficial lung tissue using deep neural network (DNN) and wave speed measurements obtained from LUSWE. The synthetic training dataset (7,88,000 in total) in terms of wave speeds of superficial lung tissue at different excitation frequencies from LUSWE, viscoelasticity and density of lung tissue was used to train the DNN. DNN is composed of 3 hidden layers of 1024 neurons and trained for 10 epochs with a batch size of 4096 and a learning rate of 0.001 with Adam optimizer. Test dataset in terms of wave speeds at different excitation frequencies (100, 150, and 200 Hz) as well as elasticity was used to predict the lung density and evaluate its accuracy. The obtained results showed that predictions matched well with test dataset (validation accuracy is 0.997). This method may be useful to analyze lung density based on the LUSWE measurements.
Quantifying nonlinear elasticity modulus of tissue-like solids using acoustic radiation force
Panahandeh-Shahraki, Danial, Kinnick, Randall R., Ghavami, Siavash , Guzina, Bojan B. , Kumar, Viksit , Urban, Matthew W. , Alizad, Azra , Fatemi, Mostafa

Mayo Clinic

The Journal of the Acoustical Society of America | April 17, 2018 | Volume: 143 | Issue: 3_Supplement | Pages: 1802-1802

10.1121/1.5035900 Get It

As shown in a recent study, estimation of the magnitude of the acoustic radiation force (ARF) in isotropic tissue-like solids is the key to measuring a third-order nonlinear modulus of elasticity (C)—responsible for coupling the shear and volumetric constitutive responses of a material. Due to experimental limitations, a direct measurement of the ARF in tissue is however difficult. To overcome this problem, we deploy 3D elastodynamic finite element (EFE) simulations of the ARF experiment in tissue-mimicking phantoms to estimate (i) the “background” shear modulus from the phase of the induced shear waves; (ii) the ARF magnitude from the shear wave amplitude, and (iii) the modulus C from the knowledge of the ARF. In this way, by interpreting the ARF-generated shear waves through the prism of 3D-EFE simulations, we facilitate local estimation of the nonlinear C modulus with spatial resolution equaling the size of the focal region. We call this method the C-Elastography (CE). In this study, the CE technique is applied to gelatin phantoms containing an agar-based inclusion. The profiles of the C-modulus in phantoms tested demonstrate good correlation with the phantom geometry, showing marked (and sharp) C-contrast at push points acting on the inclusion. [Acknowledgment: NIH-Grant EB23113.]
Parametric phantom study of shear wave velocity image reconstruction
Racedo, Jorge , Urban, Matthew W.

Mayo Clinic

The Journal of the Acoustical Society of America | April 17, 2018 | Volume: 143 | Issue: 3_Supplement | Pages: 1802-1802

10.1121/1.5035899 Get It

Shear wave elastography is being increasingly used for multiple applications including investigation of diffuse disease in the liver or kidney and malignancies or neoplasms in the breast and thyroid. It is important to provide robust and accurate reconstructions of shear wave velocity (SWV) for imaging purposes to provide reliable data for diagnosis. One such approach was a two-dimensional method for estimating SWV (Song, et al., Ultrasound Med. Biol. 40, pp. 1343–1355, 2014). This method uses a weighted average using a large window and smaller patches to perform time-domain cross-correlations for the calculation of the SWV. We also implemented a spatial sigmoid weighting to combine reconstruction results from independent reconstructions after directional filtering. We used a Verasonics system equipped with a linear array transducer to conduct a parametric study in phantoms to investigate the effects of the window and patch on image reconstruction metrics. Measurements were made in homogeneous phantoms and in a phantom with cylindrical inclusions of different diameters. Larger windows and patches typically yielded low variability but did not always produce the highest contrast. This investigation is the basis for an adaptive method for reconstructing SWV in soft tissues and choosing optimal parameters for the SWV reconstruction.
Vibro-acoustic method for detection of osteopenia and osteoporosis
Ghavami, Siavash , Gregory, Adriana , Webb, Jeremy, Denis, Max , Bayat, Mahdi , Fatemi, Mostafa , Alizad, Azra

Mayo Clinic

The Journal of the Acoustical Society of America | April 17, 2018 | Volume: 143 | Issue: 3_Supplement | Pages: 1801-1801

10.1121/1.5035894 Get It

Early detection of osteopenia and osteoporosis is critical in identifying at-risk groups and manage necessary therapy. In this paper, a new noninvasive and quantitative vibro-acoustic method is proposed for detection of osteoporosis and osteopenia. In this method, we excite the bone by an ultrasound radiation force (URF) pulse. The URF pulse induces a vibration in the bone, resulting an acoustic wave that is received by a hydrophone placed on the skin. This prospective study included n = 23 volunteers. The number of volunteers with osteopenia and osteoporosis were 7, 6, respectively, and the number of volunteers with normal bone was 10. URF excitations were applied at four equi-distance points on the bone. The resulting acoustic signals were used for wave velocity estimation based on cross-correlation technique. In general, the hydrophone signal may be modeled as a superposition of different modes of bone vibration. Based on this model, we used variational mode decomposition (VMD) as an efficient technique to decompose the received signal into an ensemble of band-limited intrinsic mode functions. Statistical analysis demonstrates that osteopenia and osteoporosis bones can be differentiated from normal bone with p< 0.001 using Wilcoxon rank-sum test on estimated velocity of the modes with maximum power.
Fast simulations of shear waves generated by an acoustic radiation force: Comparisons with measurements in shear wave phantoms
Yang, Yiqun , McGough, Robert J., Urban, Matthew W.

Mayo Clinic

The Journal of the Acoustical Society of America | April 17, 2018 | Volume: 143 | Issue: 3_Supplement | Pages: 1774-1774

10.1121/1.5035805 Get It

We recently developed a fast approach for simulating shear waves generated by an acoustic radiation force. The input for these simulations is generated in FOCUS, the “Fast object-oriented C + + simulator” (www.egr.msu.edu/~fultras-web), which rapidly models the three-dimensional (3D) pressure, intensity, and acoustic radiation force on a desktop computer. The shear waves generated by the acoustic radiation force are then quickly simulated with Green's functions for viscoelastic media in a two-dimensional (2D) plane on a high-performance graphics processing unit (GPU). For these simulations, an L7-4 linear array is electronically focused at a depth of 25 mm to generate an acoustic radiation force “push” for 200 microseconds. The simulation results are compared to shear wave data measured in three viscoelastic shear wave phantoms with low, medium, and high values of the shear viscosity using a Verasonics Vantage ultrasound system. The measured and simulated shear wave data are compared for several different combinations of the simulation parameters, where these comparisons are enabled by the rapid acoustic radiation force and shear wave simulations. The results show that the shear waves simulated in 2D planes achieve good agreement with the measured shear wave data. [Work supported in part by NIH Grants EB023051 and DK092255.]
Magnetic resonance elastography inversions: Technical challenges and recent developments
Manduca, Armando

Mayo Clinic

The Journal of the Acoustical Society of America | April 17, 2018 | Volume: 143 | Issue: 3_Supplement | Pages: 1773-1773

10.1121/1.5035803 Get It

Magnetic resonance elastography (MRE) is a phase contrast based MRI imaging technique that can quantitatively and non-invasively measure full 3D vector displacement data from propagating acoustic waves in vivo. The data acquired allow the calculation of local values of complex shear modulus and the generation of images that depict the viscoelastic properties of tissue. Acquisitions at different frequencies can capture the dispersive behavior of these quantities, and advanced approaches attempt to map anisotropic and poroelastic properties of materials. We will discuss current approaches for the inversion of MRE data, focusing on the issues and assumptions involved, and highlight some of the challenges faced in such inversions, particularly in thin or small structures in which wave propagation is dominated by waveguide effects. We will also present results based on neural network inversions, which may have lower repeatability error and be more resistant to noise than some current approaches.
Efficient computational algorithms for modeling guided wave dispersion in arterial walls
Aquino, Wilkins , Greenleaf, James F. , Gohar, Ali Vaziri , Urban, Matthew W. , Guddati, Murthy N.

Mayo Clinic

The Journal of the Acoustical Society of America | April 17, 2018 | Volume: 143 | Issue: 3_Supplement | Pages: 1774-1774

10.1121/1.5035806 Get It

Arterial stiffness is a well-known biomarker of early cardiovascular disease. Shear wave dispersion ultrasound vibrometry (SDUV) has emerged as a promising technique to estimate local arterial stiffness from the observed dispersion of guided waves. With the ultimate goal of developing real-time inversion for arterial stiffness from SDUV measurements, we develop and validate highly efficient and accurate computational algorithms that compute the wave dispersion in multi-layered immersed tubes. The proposed approach carefully combines Fourier transformation and one-dimensional finite-element discretization to accurately capture fully three-dimensional wave propagation. The method is several orders of magnitude more efficient than three-dimensional finite element simulation, and eliminates other complexities such as the need for absorbing boundary conditions. The method is validated using SDUV experiments on tissue-mimicking phantoms. The validation exercise uncovered an important detail that is often overlooked—the dispersion curve captured through SDUV experiments does not correspond to a single dispersion curve, but a combination of multiple dispersion curves. This implies that proper identification of the dispersion curves could be critical to estimating the arterial stiffness. In this talk, we present the details of the proposed method including formulation, computational complexity, verification and validation.
Magnetic resonance elastography: Status of clinical applications
Ehman, Richard L.

Mayo Clinic

The Journal of the Acoustical Society of America | April 17, 2018 | Volume: 143 | Issue: 3_Supplement | Pages: 1773-1773

10.1121/1.5035802 Get It

Magnetic resonance elastography (MRE) is an imaging technology that has been available as an FDA-cleared upgrade to MRI systems since 2009. Worldwide, MRE technology has been installed on approximately 1000 MRI systems. In October 2017, the AMA approved the creation of a CPT code for MRE. In MRE, propagating shear waves in the range of 30–300 Hz are generated in tissue, and imaged with a phase contrast MRI technique. The wave images are processed with an inversion algorithm to generate cross-sectional images quantitatively depicting the complex shear modulus of tissue. The main application of MRE is currently in noninvasive diagnosis of chronic liver disease. Published studies have established the MRE is the most accurate and technically successful non-invasive modality for diagnosing liver fibrosis. Many other promising applications of MRE are being explored by investigators around the world, including assessment of diseases of the brain, heart, lung, and muscle and tumors of breast, liver, prostate, liver, and other organs. The new applications that closest adoption in clinical practice are (1) assessment of brain disease and (2) advanced diagnosis of liver disease. These new applications require acquisition sequences and processing algorithms that are more advanced than the current product MRE techniques.
Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG-N0377, Alliance)
Aguilera, Jesus Vera, Rao, Ravi D. , Allred, Jacob B., Windschitl, Harold E., Kaur, Judith S. , Maples, William J., Lowe, Val J. , Creagan, Edward T. , Vera Aguilera, Jesus, Suman, Vera J. , Erickson, Lori A. , Markovic, Svetomir N.

Mayo Clinic

The Oncologist | April 17, 2018 | Volume: 23 | Issue: 8 | Pages: 887-e94

10.1634/theoncologist.2018-0100 | PMID 29666297 Get It

Abstract Lessons Learned Everolimus does not have sufficient activity to justify its use as single agent in metastatic melanoma. Patients treated with 10 mg per day dose were most likely to require dose reductions. Everolimus appeared to reduce the numbers of regulatory T cells in approximately half of the treated patients; unfortunately, these effects were not correlated with clinical outcomes. Background Everolimus (RAD-001) is an orally active rapamycin analogue shown in preclinical data to produce cytostatic cell inhibition, which may be potentially beneficial in treating melanoma. We conducted a phase II study to evaluate the efficacy and safety of everolimus in patients with unresectable metastatic melanoma (MM). Methods This study included two cohorts; cohort 1 received 30 mg of everolimus by mouth (PO) weekly, and cohort 2 was dosed with 10 mg of everolimus PO daily. The endpoints of the study were safety, 16-week progression-free survival (PFS), overall survival (OS), and measures of immunomodulatory/antiangiogenic properties with therapy. Tumor samples before therapy and at week 8 of treatment were analyzed. Peripheral blood plasma or mononuclear cell isolates collected prior to therapy and at weeks 8 and 16 and at time of tumor progression were analyzed for vascular endothelial growth factor and regulatory T-cell (Treg) measurements. Results A total of 53 patients were enrolled in cohort 1 (n = 24) and cohort 2 (n = 29). Only 2 patients of the first 20 patients enrolled in cohort 2 had treatment responses (25%; 95% confidence interval, 8.6%–49.1%); this result did not allow full accrual to cohort 2, as the study was terminated for futility. Median OS was 12.2 months for cohort 1 versus 8.1 months in cohort 2; no PFS advantage was seen in either group (2.1 months vs. 1.8 months). Dose-limiting toxicities included grade 4 myocardial ischemia (3.4%); grade 3 fatigue, mucositis, and hyperglycemia (10.3%); and anorexia and anemia (6.9%). Everolimus significantly reduced the number of Tregs in approximately half of the treated patients; however, these effects were not correlated with clinical outcomes. Conclusion Everolimus does not have sufficient single-agent activity in MM; however, we have identified evidence of biological activity to provide a potential rationale for future combination studies.
Outcomes of Anatomic Total Shoulder Arthroplasty with B2 Glenoids
Luedke, Colten, Kissenberth, Michael J. , Tolan, Stefan J., Hawkins, Richard J. , Tokish, John M.

Mayo Clinic

JBJS Reviews | April 17, 2018 | Volume: 6 | Issue: 4 | Pages: e7-e7

10.2106/jbjs.rvw.17.00112 | PMID 29664870 Get It

Background: Total shoulder arthroplasty remains an effective procedure for shoulder pain relief. Despite the negative effect of abnormal glenoid morphology and specifically retroverted and posteriorly subluxated glenoids, there is no consensus for management of B2 glenoids in total shoulder arthroplasty. The purpose of this study was to compare the outcomes and complication rates for B2 glenoid techniques so as to provide a baseline understanding of the current state of treatment of this pathology. Methods: A systematic review evaluating outcomes of total shoulder arthroplasty with biconcave glenoids using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) methodology included searches up to December 31, 2015, of PubMed, Embase, MEDLINE, Cochrane Reviews, and Google Scholar. Nine articles met inclusion and exclusion criteria. Results: In this study, 239 total shoulder arthroplasties with B2 glenoids with a mean follow-up of 55.5 months (range, 24 to 91 months) were included. The mean patient age was 63.3 years (range, 55.8 to 68.7 years). Asymmetric reaming was performed in 127 glenoids, posterior bone-grafting was included in 53 glenoids, and 34 received an augmented glenoid component to correct glenoid retroversion and bone loss. Overall, the mean Constant and Neer scores improved from preoperative measures. Fifty-eight percent of patients had no loosening, and 42% had some loosening, although not all of these patients were symptomatic. Despite variation in outcome measures hindering treatment approach comparison, the posteriorly augmented glenoid was generally reported to provide better outcomes with few complications. Although posterior glenoid bone-grafting results in acceptable outcomes, it also represents the highest rate of complications. The revision rate was 15.6% for asymmetric reaming, 9.5% for posterior glenoid bone-grafting, and 0% for posteriorly augmented glenoids. Conclusions: Surgical treatment of the B2 glenoid remains a challenge to the shoulder surgeon, with worse outcomes and higher complication rates. Longer follow-up, consistent outcome measures, and result stratification based on glenoid type may allow for direct comparison in the future. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.